{
    "2019-04-24": [
        [
            {
                "time": "2019-04-24",
                "original_text": "Johnson & Johnson to Host Pharmaceutical Business Review",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Pharmaceutical",
                        "Business Review"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-04-24",
                "original_text": "7 Companies With Unacceptable CEO-Worker Wage Gaps",
                "features": {
                    "keywords": [
                        "CEO-Worker",
                        "Wage Gaps"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-04-24",
                "original_text": "Everything You Need to Know About Investing in Healthcare",
                "features": {
                    "keywords": [
                        "Investing",
                        "Healthcare"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-24",
                "original_text": "Biogen (BIIB) Beats on Q1 Earnings, Spinraza Drives Sales",
                "features": {
                    "keywords": [
                        "Biogen",
                        "Q1 Earnings",
                        "Spinraza",
                        "Sales"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-24",
                "original_text": "Approach Microsoft Stock Cautiously as it Goes Into Earnings",
                "features": {
                    "keywords": [
                        "Microsoft",
                        "Stock",
                        "Cautiously",
                        "Earnings"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-04-24",
                "original_text": "Health Care Sector Update for 04/24/2019: ANTM, RAD, JNJ, PFE, ABT, MRK, AMGN",
                "features": {
                    "keywords": [
                        "Health Care",
                        "Sector Update",
                        "ANTM",
                        "RAD",
                        "JNJ",
                        "PFE",
                        "ABT",
                        "MRK",
                        "AMGN"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-24",
                "original_text": "Jim Cramer Gives His Opinion On Barrick Gold, Canopy Growth, EA, Johnson & Johnson And More",
                "features": {
                    "keywords": [
                        "Jim Cramer",
                        "Barrick Gold",
                        "Canopy Growth",
                        "EA",
                        "Johnson & Johnson"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "diverse"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-24",
                "original_text": "Exploring JNJâ€™s Key Oncology Assets in the First Quarter",
                "features": {
                    "keywords": [
                        "JNJ",
                        "Oncology Assets",
                        "First Quarter"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}